SENS

Frederick T. Sullivan

Known title: Chief Financial OfficerCIK: 0001944539

Frederick T. Sullivan's purchase track record

Frederick T. Sullivan has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
11/7/2025SENS$32K+23.6%-16.3%
12/12/2024SENS$47K+31.6%+20.6%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 30, 2026

Beta Bionics and Senseonics announce iLet-Eversense 365 integration. Beta Bionics and Senseonics announced a deal to integrate the iLet automated insulin delivery system with the Eversense 365 continuous glucose monitor. This partnership aims to provide a more seamless solution for patients managing diabetes. The news highlights a strategic move to combine two major technologies in the diabetes care market.

this person other insiders at SENS

Transaction History

SENS▼ Sell$39K
SENS▲ Buy$0
SENS▼ Sell$52K
SENS▼ Sell$40K
SENS▲ Buy$32K
SENS▼ Sell$14K
SENS▲ Buy$0
SENS▼ Sell$62K
SENS▲ Buy$47K
SENS▼ Sell$51K
SENS▼ Sell$31K
SENS▲ Buy$0
SENS▼ Sell$51K
SENS▼ Sell$62K
SENS▼ Sell$42K
SENS▼ Sell$49K
SENS▲ Buy$0
SENS▼ Sell$60K
SENS▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.